Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells
Open Access
Abstract
Temozolomide (TMZ) is standard treatment for glioblastoma (GBM); nonetheless, resistance and tumor recurrence are still major problems. In addition to its association with recurrent GBM and TMZ resistance, ALDH1A3 has a role in autophagy-dependent ferroptosis activation. In this study, we treated TMZ-resistant LN229 human GBM cells with the ferroptosis inducer RSL3. Remarkably, TMZ-resistant LN229 clones were also resistant to ferroptosis induction, although lipid peroxidation was induced by RSL3. By using Western blotting, we were able to determine that ALDH1A3 was down-regulated in TMZ-resistant LN229 cells. Most intriguingly, the cell viability results showed that only those clones that up-regulated ALDH1A3 after TMZ withdrawal became re-sensitized to ferroptosis induction. The recovery of ALDH1A3 expression appeared to be regulated by EGFR-dependent PI3K pathway activation since Akt was activated only in ALDH1A3 high clones. Blocking the EGFR signaling pathway with the EGFR inhibitor AG1498 decreased the expression of ALDH1A3. These findings shed light on the potential application of RSL3 in the treatment of glioblastoma relapse.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (68647618)
This publication has 25 references indexed in Scilit:
- Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated LipogenesisClinical Cancer Research, 2016
- Oxidative stress triggers lipid droplet accumulation in primary cultured hepatocytes by activating fatty acid synthesisBiochemical and Biophysical Research Communications, 2015
- A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulationsOncotarget, 2015
- Stem cell-like ALDHbrightcellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibininCell Cycle, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Down-regulation of EGFR prolonged cell growth of glioma but did not increase the sensitivity to temozolomide.2011
- Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacityNeuro-Oncology, 2010
- Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cellsJournal of Neuro-Oncology, 2009
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenograftsNeuro-Oncology, 2009
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology and Medicine, 2008